A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems

Clinical trial NCT03842761 · COMPLETED

Trial details

NCT number: NCT03842761
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Hepatic Insufficiency

Start date: 2019-03-06
Primary completion: 2021-04-09
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.